Posts Tagged ‘Vivus’

Vivus (VVUS) Rising on New Drug Prospect

1:00pm (EST) Vivus (VVUS, $8.40, up $0.32) is back in the spotlight but this time it’s not for news concerning its diet drug, Qnexa.  We have mentioned the battle between Vivus and others to be the first company to get a diet pill approved but Vivus also has plans toRead more

More

Futures Pointing Towards Lower Start

9:00am (EST) The bulls got a curve ball before the closing bell and had their four-session winning streak snapped as the market ended Tuesday mixed.  We covered the major resistance levels yesterday which kept a lid on things as the bears mounted a small comeback in the final hour of trading. TheRead more

More

Goldman Sachs (GS) Settles, Google (GOOG) Misses, Vivus (VVUS) Gets Slammed

9:00am (EST) We’ve got a long way to go and a short time to get there… There is so much news to cover this morning we feel like Smokey and the Bandit.  We have a number of interesting tidbits to go over and the opening bell rings in 30 minutes…but we will get youRead more

More

Bears See An Opening

1:00pm (EST) The bulls are having a tough day and you don’t need us to tell you the market may have reached a temporary “top” again.  There is a bevy of news that is happening today AND tomorrow so we will do some quick hits today. The Dow is currentlyRead more

More

Rally Stalls After Weak Retail Sales

1:00pm (EST) When we shut our eyes this morning around 2am, the Dow futures were up 70 points and it appeared as though the bulls were going to have a huge day.  However, when we woke up this morning and were doing the finishing touches to our 9am update, futuresRead more

More

Bulls Resting, Will Bears Show Up Next Week?

1:00pm (EST) The market has traded in a tight range although the bulls are still the fat kid on the see-saw.  The major indexes are showing slight gains as traders seem tentative to build positions ahead of 2Q earnings. The Dow is up 5 points to 10,144 while the S&PRead more

More

Vivus (VVUS) Back Peddles On New Concerns

1:00pm (EST) The market is trading in a tight range as the bulls try to push the Dow higher for a fourth straight session.  The index’s 3-day winning streak has been its first since April as the bulls also look to take the market to higher ground for the second straightRead more

More

Eye On The Prize

9:00am (EST) It is amazing the price swings stocks and options can go through.  The best part about being an option trader is that there is always a trade out there.  With so many sectors and ways to use options, the possibilities are endless as sectors get hold or coldRead more

More

Bulls Looking For Momentum

9:05am (EST) The market got off to a good start for 2010 as the Dow rallied 155 points to close at 10,583.  In the process, the index made a 52-week high and was followed by strong gains in the Nasdaq (up 39 points to 2,308) and the S&P 500 (upRead more

More

Orexigen Therapeutics Up Sharply After-Hours

Orexigen Therapeutics (OREX, $5.89, down $0.10) was up sharply in after-hours trading on news that the company could be announcing something concerning its treatment drug for obesity, Contrave. The company will presenting at a JPMorgan (JPM, $29.25, down $2.10) conference next week which means the rumor mill got started earlyRead more

More

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.